Multiple sclerosis

Guidelines (8)
Drug Sections (1)

Multiple sclerosis in the News

First oral short-course treatment for MS

First oral short-course treatment for MS

Mavenclad (cladribine) is licensed for the treatment...

New MS treatment accepted by NICE

New MS treatment accepted by NICE

Eligible patients with multiple sclerosis (MS) must...

Dimethyl fumarate - new measures to minimise leukoencephalopathy risk

Revised monitoring recommendations have been issued...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases